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Abstract  13 
Neuropeptides in deuterostomian invertebrates that have an Asn-Gly motif (NG peptides) have been 14 
identified as orthologs of vertebrate neuropeptide-S (NPS)-type peptides and protostomian crustacean 15 
cardioactive peptide (CCAP)-type peptides. To obtain new insights into the physiological roles of 16 
NG peptides in deuterostomian invertebrates, here we have characterised the NG peptide signalling 17 
system in an echinoderm – the starfish Asterias rubens. The neuropeptide NGFFYamide was 18 
identified as the ligand for an A. rubens NPS/CCAP-type receptor, providing further confirmation 19 
that NG peptides are orthologs of NPS/CCAP-type neuropeptides. Using mRNA in situ 20 
hybridisation, cells expressing the NGFFYamide precursor transcript were revealed in the radial 21 
nerve cords, circumoral nerve ring, coelomic epithelium, apical muscle, body wall, stomach and tube 22 
feet of A. rubens, indicating that NGFFYamide may have a variety of physiological roles in starfish. 23 
One of the most remarkable aspects of starfish biology is their feeding behaviour, where the stomach 24 
is everted out of the mouth over the soft tissue of prey. Previously, we reported that NGFFYamide 25 
triggers retraction of the everted stomach in A. rubens and here we show that in vivo injection of 26 
NGFFYamide causes a significant delay in the onset of feeding on prey. To investigate roles in 27 
regulating other aspects of starfish physiology, we examined the in vitro effects of NGFFYamide and 28 
found that it causes relaxation of acetylcholine-contracted apical muscle preparations and induction 29 
of tonic and phasic contraction of tube feet. Furthermore, analysis of the effects of in vivo injection of 30 
NGFFYamide on starfish locomotor activity revealed that it causes a significant reduction in mean 31 
velocity and distance travelled. Interestingly, experimental studies on mammals have revealed that 32 
NPS is an anxiolytic that suppresses appetite and induces hyperactivity in mammals. Our 33 
characterisation of the actions of NGFFYamide in starfish indicates that NPS/NG peptide/CCAP-34 
type signalling is an evolutionarily ancient regulator of feeding and locomotion. 35 
 36 
1 Introduction 37 
Neuropeptides are intercellular signalling molecules that are secreted by neurons to regulate a diverse 38 
range of physiological processes and behaviours in animals (Burbach, 2011; van den Pol, 2012). 39 
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They typically exert their effects on target cells by binding to and activating cognate G-protein 40 
coupled receptors (GPCRs) belonging to the rhodopsin-β, rhodopsin-γ and secretin-type receptor 41 
families (Fredriksson et al., 2003). 42 
 43 
Phylogenetic analysis has revealed that the evolutionary origin of at least 30 neuropeptide signalling 44 
systems can be traced back to the bilaterian common ancestor of deuterostomes and protostomes 45 
(Jekely, 2013; Mirabeau and Joly, 2013; Elphick et al., 2018). Interestingly, the amino acid 46 
sequences of some neuropeptides are highly conserved throughout the Bilateria, whereas other 47 
neuropeptides have diverged to such an extent that they are not immediately recognisable as 48 
orthologs based on their amino acid sequence. An example of the former are vasopressin/oxytocin 49 
(VP/OT)-type neuropeptides, which are typically C-terminally amidated cyclic nonapeptides (Beets 50 
et al., 2013). An example of the latter are a family of neuropeptides that are paralogs of VP/OT-type 51 
neuropeptides, which include neuropeptide-S (NPS) in vertebrates, crustacean cardioactive peptide 52 
(CCAP) in protostomes and NG peptides in invertebrate deuterostomes (e.g. NGFFYamide, which is 53 
the focus of this paper) (Semmens et al., 2015). 54 
 55 
NPS is a 20-residue neuropeptide (SFRNGVGTGMKKTSFQRAKS) that was first discovered in 56 
rodents (Xu et al., 2004) and has subsequently been identified throughout the tetrapod vertebrates 57 
(Reinscheid, 2007). NPS induces arousal and anxiolytic-like effects in rodents (Xu et al., 2004; Rizzi 58 
et al., 2008; Vitale et al., 2008), whilst polymorphisms in the NPS receptor (NPSR) are associated 59 
with panic disorders in humans (Okamura et al., 2007; Domschke et al., 2011). The NPS/NPSR 60 
system also regulates other physiological/behavioural processes in mammals, including locomotion 61 
(Smith et al., 2006; Okamura et al., 2008; Duangdao et al., 2009; Peng et al., 2010; Li et al., 2015), 62 
gastrointestinal functions (Camilleri et al., 2010; Wan Saudi and Sjöblom, 2017) and feeding (Smith 63 
et al., 2006; D'Amato et al., 2007; Peng et al., 2010) 64 
 65 
Orthologs of the NPSR are present in arthropods and other protostomian invertebrates (Jekely, 2013; 66 
Mirabeau and Joly, 2013) and these are activated by crustacean cardioactive peptide (CCAP)-type 67 
neuropeptides (Cazzamali et al., 2002; Park et al., 2002), which do not exhibit sequence similarity 68 
with NPS. CCAP is a 9-residue neuropeptide (PFCNAFTGC-NH2) that was first discovered in the 69 
crustacean Carcinus maenas (Stangier et al., 1987), with CCAP-type neuropeptides subsequently 70 
identified in other protostomian invertebrates (Jekely, 2013; Mirabeau and Joly, 2013). As its name 71 
implies, CCAP was initially discovered on account of its cardioacceleratory effects (Stangier et al., 72 
1987), but it has since been found to have a key role in neural control of ecdysis in crustaceans 73 
(Phlippen et al., 2000; Chung and Webster, 2004) and insects (Gammie and Truman, 1997; Belmont 74 
et al., 2006; Kim et al., 2006; Arakane et al., 2008). Furthermore, experimental studies on the 75 
cockroach Periplaneta americana have revealed that CCAP also regulates gastrointestinal activity 76 
(Sakai et al., 2006), feeding and locomotion (Mikani et al., 2015). 77 
 78 
Important insights into the evolutionary relationship between NPS-type neuropeptides in vertebrates 79 
and CCAP-type neuropeptides in protostomes have been provided by the discovery of the NG 80 
peptide signalling system in invertebrate deuterostomes, which occupy an intermediate phylogenetic 81 
position with respect to vertebrates and protostomes. Members of this neuropeptide family have a 82 
characteristic Asn-Gly (NG) motif (Elphick, 2010), which provided the basis for the name ‘NG 83 
peptide’. Sequencing of the genome of the sea urchin Strongylocentrotus purpuratus (Phylum 84 
Echinodermata) first enabled the discovery of a gene encoding an NG peptide precursor protein, 85 
which contains two tandem copies of the neuropeptide NGFFFamide (NGFFF-NH2) (Elphick and 86 
Rowe, 2009). Furthermore, the NGFFFamide precursor was found to have a C-terminal neurophysin 87 
domain, which was a surprising finding because hitherto neurophysins were thought to be uniquely 88 
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associated with the precursors of VP/OT-type neuropeptides (de Bree and Burbach, 1998; de Bree, 89 
2000). Subsequently, NG peptide precursors have been identified in other echinoderm species 90 
(Elphick, 2012; Semmens et al., 2013; Semmens et al., 2015; Zandawala et al., 2017), the 91 
hemichordate Saccoglossus kowalevskii and the cephalochordate Branchiostoma floridae (Elphick, 92 
2010). This has revealed that the presence of a C-terminal neurophysin domain is a conserved feature 93 
of NG peptide precursors, although the neurophysin domain has been lost in holothurian (sea 94 
cucumber) NG peptide precursors.   95 
 96 
Evidence that NG peptides are orthologs of vertebrate NPS-type neuropeptides was provided by 97 
analysis of the sequence of the NG peptide precursor in the cephalochordate B. floridae, which 98 
comprises two copies of a peptide (SFRNGVG) that is identical to the N-terminal region of NPS 99 
(SFRNGVGTGMKKTSFQRAKS) (Elphick, 2010). However, definitive proof was provided with the 100 
discovery that an NPS/CCAP-type receptor in the sea urchin S. purpuratus is activated by the 101 
neuropeptide NGFFFamide (Semmens et al., 2015). Thus, a bilaterian neuropeptide family 102 
comprising NPS in vertebrates, NG peptides in invertebrate deuterostomes and CCAP-type 103 
neuropeptides in protostomes was unified. Furthermore, discovery and characterisation of NG 104 
peptide signalling in deuterostomes provided a key missing link for reconstructing the evolutionary 105 
history of the paralogous VP/OT-type and NPS/CCAP-type neuropeptide signalling systems. It can 106 
be inferred that the presence of a neurophysin domain was an ancestral characteristic of the 107 
precursors of both neuropeptide families, which has then been retained in all bilaterian VP/OT-type 108 
precursors and in the NG peptide precursors of invertebrate deuterostomes but which has been lost 109 
independently in vertebrate NPS-type precursors and in protostome CCAP-type precursors (Mirabeau 110 
and Joly, 2013; Valsalan and Manoj, 2014; Semmens et al., 2015). 111 
 112 
The discovery that NG peptides are orthologs of NPS and CCAP-type neuropeptides has provided an 113 
interesting context for investigating the physiological roles of NG peptides in invertebrate 114 
deuterostomes. Currently, nothing is known about the physiological roles of NG peptides in 115 
cephalochordates or hemichordates; however, progress has been made in examining NG peptide 116 
function in echinoderms. The first NG peptide to be discovered was the myoactive neuropeptide 117 
NGIWYamide, which causes contraction of the longitudinal body wall muscle in the sea cucumber 118 
Apostichopus japonicus (Iwakoshi et al., 1995; Inoue et al., 1999). Subsequently, it has been found 119 
that NGIWYamide also acts as gonadotropic neuropeptide, triggering oocyte maturation and 120 
spawning in A. japonicus (Kato et al., 2009). Discovery of the NGFFFamide precursor in S. 121 
purpuratus facilitated investigation of the pharmacological actions of NGFFFamide in sea urchins, 122 
which revealed that it causes contraction of tube foot and oesophagus preparations from the sea 123 
urchin Echinus esculentus (Elphick and Rowe, 2009). Thus, this finding was consistent with the 124 
myotropic action of NGIWYamide in sea cucumbers.  125 
 126 
Investigation of the physiological roles of NG peptides in echinoderms was advanced most recently 127 
with the discovery of the precursor of the NG peptide NGFFYamide (NGFFY-NH2) in the starfish 128 
Asterias rubens. Research on neuropeptide systems in this species led to the discovery of the first 129 
echinoderm neuropeptides to be sequenced – the SALMFamide neuropeptides S1 and S2 (Elphick et 130 
al., 1991). S1 and S2 act as muscle relaxants in starfish and, more specifically, in vitro and in vivo 131 
pharmacological experiments revealed that S1 and S2 trigger relaxation and eversion of the stomach 132 
in A. rubens (Elphick et al., 1995; Melarange et al., 1999). This was of interest because stomach 133 
eversion occurs naturally in starfish when they feed extra-orally on prey (e.g. mussels). Therefore, it 134 
was postulated that when starfish feed, S1 and S2 may be released to enable relaxation and eversion 135 
of the stomach out of the mouth and over the digestible tissue of prey (Elphick et al., 1995; 136 
Melarange et al., 1999). Conversely, the existence of a counteracting neuropeptide that triggers 137 
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stomach contraction and retraction when feeding is completed was also postulated. Because NG 138 
peptides act as muscle contractants in sea cucumbers and sea urchins, the starfish neuropeptide 139 
NGFFYamide was tested on starfish and found to cause stomach contraction in vitro and stomach 140 
retraction in vivo (Semmens et al., 2013). 141 
 142 
Having discovered, quite specifically, that NGFFYamide acts to cause stomach contraction and 143 
retraction in starfish (Semmens et al., 2013), the aim of this study was to characterise more generally 144 
the NGFFYamide signalling system in starfish and this has been accomplished using a variety of 145 
experimental approaches. Firstly, an in vitro cell-based assay was employed to demonstrate that 146 
NGFFYamide is the ligand for an A. rubens NPS/CCAP-type receptor that was identified previously 147 
as a candidate receptor for this neuropeptide (Semmens et al., 2015). Secondly, mRNA in situ 148 
hybridisation methods were employed to investigate the anatomy of NGFFYamide precursor 149 
expression in A. rubens. Thirdly, informed by the anatomical expression pattern of the NGFFYamide 150 
precursor, the in vitro pharmacological actions of NGFFYamide on apical muscle and tube feet 151 
preparations from A. rubens were investigated. Fourthly, and informed by the in vitro and in vivo 152 
actions of NGFFYamide, effects of in vivo injection of NGFFYamide on starfish feeding behaviour 153 
and locomotor activity were examined. Collectively, the findings of this study provide important new 154 
insights into the comparative physiology of NPS/NG peptide/CCAP-type neuropeptide signalling in 155 
the animal kingdom. 156 
 157 
2 Material and methods 158 
2.1 Animals 159 
Adult starfish (A. rubens) were collected at low tide from a location near Margate (Kent, UK) or were 160 
obtained from a fisherman based at Whitstable (Kent, UK). The starfish were maintained in an 161 
aquarium with circulating artificial seawater (Tropical Marine CentreTM Premium Reef-Salt) at a 162 
salinity of 32 ‰ and at a temperature of approximately 11ºC under a 12-hour light/dark cycle. 163 
Animals were fed on mussels (Mytilus edulis) that were also collected from a location near Margate 164 
(Kent, UK) at low tide.  165 
2.2 Pharmacological characterisation of the NGFFYamide receptor 166 
We have previously reported the identification of an A. rubens NPS/CCAP-type receptor (GenBank 167 
accession number: KP171535) that is a candidate receptor for NGFFYamide (Semmens et al., 2015). 168 
Here we performed a more comprehensive phylogenetic analysis to investigate the relationship of the 169 
A. rubens NPS/CCAP-type receptor with NPS/CCAP-type receptors that have been identified and, in 170 
some cases, pharmacologically characterised in other species. Phylogenetic analysis was performed 171 
using a maximum likelihood method, with sequences aligned using the MUSCLE plugin in MEGA 172 
7 (iterative, 10 iterations, UPGMB as clustering method) (Edgar, 2004; Kumar et al., 2016). The 173 
maximum-likelihood tree was built using PhyML version 3.0 (1000 bootstrap replicates, LG 174 
substitution model) (Guindon et al., 2010) and edited using FigTree v1.4.2. 175 
(http://tree.bio.ed.ac.uk/software/figtree/).  176 
 177 
To enable pharmacological characterisation of the A. rubens NPS/CCAP-type receptor, a pUC57 178 
vector comprising the coding sequence of the receptor was custom synthesised (GenScript®), with a 179 
partial Kozak sequence (CACC) incorporated immediately preceding the start codon to optimise the 180 
initiation of translation. The full-length sequence was then sub-cloned into a pcDNA3.1TM (+) 181 
mammalian expression vector using the blunt-end restriction endonuclease EcoRV. A plasmid 182 
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maxiprep was subsequently performed using the QIAGEN Plasmid Maxi Kit (QIAGEN). To 183 
determine whether synthetic NGFFYamide (NGFFY-NH2; Peptide Protein Research Ltd.) acts as a 184 
ligand for the A. rubens NPS/CCAP-type receptor, a receptor deorphanisation assay was performed 185 
at concentrations ranging from 10-20 M to 10-4 M using the same methodology as reported recently 186 
for deorphanisation of A. rubens luqin-type receptors (Yañez-Guerra et al., 2018). Responses were 187 
normalised to the maximum response obtained in each experiment (100% activation) and to the 188 
response obtained with the vehicle media (0% activation). Concentration-response curves were 189 
fitted with a four-parameter curve and EC50 values were calculated from concentration-response 190 
curves using Prism 6 (GraphPad), which were based on triplicate measurements from at least two 191 
independent transfections. 192 
 193 
2.3 Localisation NGFFYamide precursor expression using mRNA in situ hybridisation 194 
Cloning of a cDNA encoding the NGFFYamide precursor (GenBank accession number: KC977457) 195 
and the subsequent production of digoxigenin-labelled sense and anti-sense RNA probes has been 196 
reported previously (Mayorova et al., 2016). The methods employed for (i) preparation of paraffin-197 
embedded sections of fixed specimens of A. rubens and (ii) visualisation of NGFFYamide precursor 198 
transcripts in sections of A. rubens were the same as reported recently for analysis of the expression 199 
of other neuropeptide precursors (Lin et al., 2017; Tian et al., 2017; Lin et al., 2018). 200 
 201 
2.4 In vitro pharmacology  202 
We have previously reported that NGFFYamide causes concentration-dependent contraction of 203 
cardiac stomach preparations from A. rubens (Semmens et al., 2013). Here, NGFFYamide was tested 204 
in vitro to investigate its effect on apical muscle and tube foot preparations from A. rubens, using the 205 
same methods reported previously when testing other neuropeptides (Melarange and Elphick, 2003; 206 
Lin et al., 2017; Tian et al., 2017). Briefly, the apical muscle was dissected from the aboral body wall 207 
of starfish arms and cut into segments approximately 1 cm in length and cotton ligatures were tied at 208 
each end. Tube foot preparations were obtained by dissecting from starfish arms a small square-209 
shaped piece of ambulacral body wall containing a single tube foot podium and its associated 210 
ampullae. Cotton ligatures were tied around the body wall and the tube foot sucker and then the tube 211 
foot was scraped with a blunt scalpel blade to partially remove the external epithelial layer to 212 
facilitate accessibility of the underlying muscle layer to NGFFYamide when tested. Apical muscle or 213 
tube foot preparations were linked to an isotonic force transducer and maintained in a 20 ml aerated 214 
organ bath containing circulating artificial sea water at 11 °C. Once a stable baseline was reached, 215 
acetylcholine (ACh, 10-6 M), a known contractant of starfish apical muscle and tube feet (Protas and 216 
Muske, 1980; Tian et al., 2017), was tested to check the viability of preparations and to enable 217 
normalisation of excitatory effects of NGFFYamide or facilitate detection of relaxing effects of 218 
NGFFYamide (Elphick et al., 1995; Elphick and Melarange, 1998; Melarange and Elphick, 2003). 219 
Synthetic NGFFYamide (prepared in distilled water) was added to the organ bath to achieve 220 
concentrations of 10-6 M and 10-5 M when tested on apical muscle preparations and from 10-9 - 10-6 M 221 
when tested on tube foot preparations. Each peptide concentration was tested on at least four 222 
individual preparations. A relaxant effect of NGFFYamide on apical muscle preparations was 223 
expressed as a percentage reversal of the maximal contraction induced by 10-6 M ACh. For tube foot 224 
preparations, tonic contractions induced by NGFFYamide and the peak amplitude of phasic 225 
contractions induced by NGFFYamide were expressed as a percentage of the maximal contraction 226 
induced by 10-6 M ACh. For phasic contractions, peak amplitude and frequency were quantified over 227 
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a five-minute recording period and expressed as mean amplitude and mean peaks/minute, 228 
respectively. For in vitro characterisation of the effects of NGFFYamide on tube foot preparations, a 229 
concentration-response curve was fitted with a four-parameter curve and the EC50 value was 230 
calculated based on six measurements. The in vitro effect of NGFFYamide on basal tone was 231 
analysed by a one-way ANOVA using Bonferroni's multiple comparisons post-hoc test. The in vitro 232 
effect of NGFFYamide on peak frequency and amplitude was analysed by a Kruskal-Wallis non-233 
parametric test using Dunn’s multiple comparisons post-hoc test because these data were found to be 234 
not normally distributed when analysed using the Kolmogorov-Smirnov test. All the statistical 235 
analyses were carried out using Prism 6 (GraphPad). 236 
 237 
2.5 In vivo pharmacology 238 
2.5.1 Investigation of effects of NGFFYamide on starfish feeding behaviour 239 
Previously, we reported that NGFFYamide triggers contraction and retraction of the cardiac stomach 240 
in A. rubens, indicating that this neuropeptide has a physiological role in neural control of the extra-241 
oral feeding behaviour of starfish (Semmens et al., 2013). Here, we investigated if in vivo injection of 242 
NGFFYamide affects the feeding behaviour of A. rubens on a prey species – the mussel Mytilus 243 
edulis.  For these experiments, 32 adult starfish that met the following criteria were used: (i) all five 244 
arms were intact, (ii) exhibited a normal righting response (Lawrence and Cowell, 1996) and (iii) 245 
after 24 days of starvation, exhibited normal feeding behaviour on a mussel. The selected individuals 246 
were then maintained in an aquarium with circulating seawater but without food for 24 days. The 247 
starfish were then transferred to and kept individually in Plexiglas aquaria (27.5 x 19 x 19.6 cm) 248 
containing 6 l of aerated seawater and with the base covered by gravel (Tropical Marine CentreTM 249 
Gravel Coarse #5). The exterior of the sides and base of the aquarium tanks was covered with black 250 
plastic. These animals were then divided into a control group (to be injected with distilled water) of 251 
15 animals (mean diameter of 11.9 ± 0.3 cm) and a test group (to be injected with NGFFYamide) of 252 
17 animals (mean diameter of 12.5 ± 0.3 cm). After three days of acclimation (27 days of starvation), 253 
the starfish were injected with 10 µl of distilled water (control group) or 10 µl of 10-4 M synthetic 254 
NGFFYamide (test group). This peptide dose was selected for the test group because the volume of 255 
the perivisceral coelomic fluid in starfish with a diameter of 11-13 cm is ~ 10 ml and therefore the 256 
estimated final concentration of NGFFYamide in the perivisceral coelom is ~ 10-7 M, which is the 257 
concentration at which NGFFYamide was found to have a maximal effect when tested previously on 258 
in vitro preparations of the cardiac stomach (Semmens et al., 2013). Hamilton 75N 10 µl syringes 259 
(Sigma) were used to inject distilled water or NGFFYamide solution into the perivisceral coelom of 260 
animals at two opposite sites (5 µl each) in the aboral body wall of arms, proximal to the junction 261 
with the central disk region. Care was taken to inject the distilled water/NGFFYamide into the 262 
perivisceral coelom and not into the cardiac stomach. Ten minutes after injection, one mussel (25-33 263 
mm) that had been cleaned of any encrusting organisms (Hummel et al., 2011) was placed at one end 264 
of the tank approximately 15 cm from the starfish, whilst also ensuring that one arm of the starfish 265 
was touching the wall of the opposite end of the tank with the madreporite directed towards the 266 
mussel. Starfish behaviour was continuously observed for three hours, followed by observations at 15 267 
minute intervals for two hours and then a final observation 24 hours later. The time taken for the 268 
starfish to make contact with the mussel (tube feet touching the mussel; time to touch; Figure 1A), 269 
the number of attempts to touch and the time to enclose the mussel (indicated by a feeding posture; 270 
Figure 1B-C) was recorded. Starfish that were feeding after 24 hours were included in data analysis 271 
and any starfish in the control or test group that had not fed on a mussel after 24 hours were 272 
discarded from data analysis. The effect of NGFFYamide on feeding behaviour was analysed by a 273 
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two-tailed Student’s t-test (time to touch) or Welch’s unequal variances t-test (time to enclose) using 274 
Prism 6 (GraphPad). 275 
 276 
2.5.2 Investigation of the effects of NGFFYamide on locomotor activity 277 
To investigate if NGFFYamide affects locomotor activity in A. rubens, 27 adult starfish that had five 278 
arms intact and exhibited a normal righting response (Lawrence and Cowell, 1996) were selected for 279 
testing. A total of 13 animals were injected with distilled water for the control group (mean diameter 280 
of 10.6 ± 0.3 cm) and 14 animals were injected with NGFFYamide for the test group (mean diameter 281 
10.4 ± 0.2 cm). Animals in both groups were starved for one week to ensure that the feeding status of 282 
all animals were similar. The starfish were then transferred to and kept individually in Plexiglas 283 
aquaria (27.5 x 19 x 19.6 cm) containing 6 l of aerated seawater and injected with 10 µl of distilled 284 
water  or 10-4 M NGFFYamide, employing the same method as reported above in section 2.5.1. Ten 285 
minutes after the injection, starfish were transferred individually to the centre of a Plexiglas aquarium 286 
(37 x 19.8 x 25 cm) containing 7 l of seawater, with all the walls covered with white plastic and 287 
situated on top of a lightbox to enhance video contrast (Figure 2A). Starfish activity was then video 288 
recorded from above with a camera (Canon EOS 700D; Figure 2A) for six-and-a-half minutes. 289 
Video files (MPEG-4) were then analysed using the video-tracking software Ethovision XT1 (version 290 
11.5, Noldus; Figure 2B-C). The first 30 seconds of each six-and-a-half minute video recording were 291 
discarded from the analysis to avoid interference caused by starfish handling and surface water 292 
movement during these periods. The mean velocity, total distance travelled, maximum acceleration 293 
and cumulative time spent on the floor (over an entire six-minute period) as well as mean velocity 294 
and total distance travelled (during time intervals of one-minute) were calculated. The effect of 295 
NGFFYamide on mean velocity, total distance travelled and cumulative time spent on the floor (over 296 
an entire six-minute period) were analysed using a two-tailed Student’s t-test. The mean value of 297 
maximum acceleration (over an entire six-minute period) and mean velocity and total distance 298 
travelled (during the time intervals 1-2 and 3-4 minutes) were analysed using a two-tailed Mann-299 
Whitney U-test. The mean velocity and total distance travelled (during time intervals of one-minute) 300 
in control and NGFFYamide treated groups were analysed by a Kruskal-Wallis non-parametric test 301 
using Dunn’s multiple comparisons post-hoc test. The Mann-Whitney U-test and Kruskal-Wallis 302 
non-parametric test were used as these data were found not to be normally distributed by the 303 
Kolmogorov-Smirnov normality test. All statistical analyses were carried out using Prism 6 304 
(GraphPad). 305 
 306 
3 Results 307 
3.1 NGFFYamide is a potent ligand for the A. rubens NPS/CCAP-type receptor 308 
Phylogenetic analysis of NPS/CCAP-type and paralogous VP/OT-type receptors revealed that the A. 309 
rubens NPS/CCAP-type receptor groups with ambulacrarian NPS-type receptors, including the 310 
recently characterised sea urchin (S. purpuratus) NGFFFamide receptor (Figure 3A). To determine 311 
whether NGFFYamide is the cognate ligand for the A. rubens NPS/CCAP-type receptor, the receptor 312 
was expressed in a CHO-cell line over-expressing mitochondrially targeted GFP-aequorin fusion 313 
protein (G5A) to assay for elevation of calcium (Ca2+) levels. To enable this, the receptor was co-314 
transfected with the promiscuous human Gα16 protein, which couples to the phospholipase-C-β 315 
(PLC-β) pathway to trigger Ca2+ release from intracellular stores.  Synthetic NGFFYamide (NGFFY-316 
NH2) was tested at concentrations ranging from 10−20 M to 10−4 M and induced concentration-317 
dependent Ca2+ elevation, with a half-maximal response concentration (EC50) of 2.1 x 10-13 M 318 
(Figure 3B). Control experiments on cells transfected with an empty pcDNA 3.1 (+) vector revealed 319 
                                                               NGFFYamide regulates feeding and locomotion in starfish 
 
8 This is a provisional file, not the final typeset article 
no effect of NGFFYamide on Ca2+ levels (Figure 3B). Thus, NGFFYamide was identified as a 320 
highly potent ligand for the A. rubens NPS/CCAP-type receptor.  321 
3.2 Analysis of NGFFYamide precursor expression using mRNA in situ hybridisation 322 
Analysis of the expression of NGFFYamide precursor mRNA transcripts in A. rubens (see (Moore 323 
and Thorndyke, 1993; Blowes et al., 2017) for detailed descriptions of A. rubens anatomy) revealed a 324 
widespread pattern of expression. This included stained cells in the nervous system (Figure 4A-E), 325 
digestive system (Figure 5A-F), tube feet (Figure 6A-C), coelomic epithelium (Figure 6D), apical 326 
muscle (Figure 6E) and body wall (Figure 6F), as described in more detail below. 327 
3.2.1. NGFFYamide precursor expression in the nervous system  328 
The A. rubens nervous system is comprised of radial nerve cords extending along the oral side of 329 
each arm, which are linked in the central disk by a circumoral nerve ring. Marginal nerves run 330 
parallel with the radial nerve cords, lateral to the outer row of tube feet on each side of the arm. 331 
Analysis of NGFFYamide precursor mRNA expression revealed stained cells in the ectoneural 332 
region of the radial nerve cords; no stained cells were observed in the hyponeural region of the radial 333 
nerve cords (Figure 4A-C). The labelled cell bodies were, largely, laterally concentrated at the 334 
periphery of the radial nerve cord in the epithelial layer of the ectoneural region (Figure 4A-C). 335 
Expression of NGFFYamide precursor mRNA was also observed in the ectoneural region of the 336 
circumoral nerve ring (Figure 4D), consistent with the expression pattern observed in the radial 337 
nerve cord. Furthermore, NGFFYamide precursor mRNA expression was also observed in the 338 
marginal nerves (Figure 4E). 339 
3.2.2. NGFFYamide precursor expression in the digestive system  340 
The oral region of the A. rubens digestive system comprises a mouth surrounded by a contractile 341 
peristomial membrane, which is continuous with a short tubular oesophagus. The oesophagus is 342 
linked aborally to a large and highly folded cardiac stomach, which is everted through the mouth 343 
during feeding. The pyloric stomach is aboral to the cardiac stomach and is linked to pyloric caeca 344 
via pyloric ducts. Aboral to the pyloric stomach is a short rectum, which has associated rectal caeca. 345 
Analysis of NGFFYamide precursor mRNA expression revealed stained cells in the cardiac stomach 346 
(Figure 5A-C) with sparser expression detected in the pyloric stomach and very sparse expression 347 
detected in the pyloric ducts (Figure 5D-F). Expression of NGFFYamide mRNA was not observed 348 
in the peristomial membrane, oesophagus, pyloric caecae or rectal caeca (data not shown). 349 
 350 
Labelled cells were more densely concentrated in the aboral region of the cardiac stomach than in the 351 
oral region of the cardiac stomach and were located in the mucosal layer, often in close proximity to 352 
the basiepithelial nerve plexus (Figure 5A-C). Labelled cells were sparsely distributed in both the 353 
pyloric stomach and pyloric ducts, where they were located in the mucosal layer in close proximity to 354 
the basiepithelial nerve plexus (Figure 5D-F).  355 
3.2.3. NGFFYamide precursor expression in tube feet, apical muscle and body wall  356 
The body wall skeleton is comprised of calcite ossicles that are interconnected by muscle and 357 
collagenous tissue. The aboral surface of the body wall has a number of appendages, including 358 
pedicellariae, spines and papulae. The oral surface of the body wall comprises ambulacral and 359 
adambulacral ossicles and two rows of tube feet, which are linked to ampullae that are located 360 
internally. Analysis of NGFFYamide precursor mRNA expression revealed stained cells in the 361 
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sucker region of tube feet (Figure 6A-C), with some stained cells closely associated with the basal 362 
nerve ring (Figure 6A-C).  363 
 364 
NGFFYamide precursor mRNA expression was observed in cells located in the coelomic epithelium, 365 
which lines the internal surface of the body wall (Figure 6D). Stained cells were also observed in the 366 
coelomic epithelial lining of the apical muscle, an aboral thickening of longitudinally oriented muscle 367 
in the arm body wall that also extends into the central disk region (Figure 6E).  Finally, a sparse 368 
population of stained cells were observed in the external epithelium of the body wall (Figure 6F). 369 
 370 
3.3 NGFFYamide causes relaxation of in vitro preparations of apical muscle and induction of 371 
tonic and phasic contraction of tube feet. 372 
NGFFYamide caused relaxation of ACh-contracted apical muscle preparations when tested at 373 
concentrations of 10-6 M and 10-5 M in vitro. However, the mean relative relaxing effect of 374 
NGFFYamide at 10-6 M was quite small, amounting to only an 11.3 ± 2.9 % reversal of the 375 
contracting effect of ACh at 10-6 M (Figure 7; n = 4). Furthermore, when tested at the higher 376 
concentration of 10-5 M, a similar modest relaxing effect of NGFFYamide was observed (12.1 ± 7.8 377 
%; data not shown; n = 4). The relaxing effect of NGFFYamide was observed when the apical 378 
muscle was contracted with 10-6 M ACh but NGFFYamide seems to have no effect on apical muscle 379 
preparations contracted with 10-5 M ACh or when the apical muscle was not pre-contracted with ACh 380 
(data not shown; n = 4). 381 
 382 
NGFFYamide had an excitatory effect on in vitro preparations of tube feet, triggering phasic 383 
contractions that were superimposed on an increase in basal tone (Figures 8-9). Thus, NGFFYamide 384 
caused concentration-dependent tonic contraction of tube foot preparations at concentrations between 385 
10-8 M and 10-6 M (n = 6; Figure 9A). The mean maximal contractile effect, 59.1 ± 12.5 % in 386 
comparison with the effect of ACh at 10-6 M (defined as 100 % contraction), was achieved at a 387 
concentration of 10-6 M (Figure 9A). The half maximal response concentration (EC50) was 1.4 x 10-8 388 
M. NGFFYamide typically induced concentration-dependent phasic contractions of tube feet 389 
preparations between 10-8 M and 10-6 M, although phasic contractions were induced at 10-9 M in one 390 
preparation (Figure 8, 9B-C). The mean maximal peak frequency (0.97 ± 0.11) and the mean 391 
maximal peak amplitude (70.9 ± 28.2 %) were achieved at a NGFFYamide concentration of 10-6 M 392 
(Figure 9B-C). 393 
 394 
It is noteworthy that the potency of NGFFYamide as a ligand for its receptor when the receptor is 395 
over-expressed heterologously in CHO-K1 cells in vitro (EC50 = 2.1 x 10-13 M; Figure 3B) is much 396 
higher than its potency in vitro as a regulator of the contractility of cardiac stomach (Semmens et al., 397 
2013), apical muscle (Figure 7) and tube foot (Figures 8-9) preparations. This probably reflects both 398 
the non-physiological over-expression of the NGFFYamide receptor in CHO-K1 cells and the 399 
reduced access of NGFFYamide to receptors in muscle/organ preparations caused by impaired 400 
penetration through tissue layers and degradation of the peptide by endogenous peptidases.    401 
3.4 NGFFYamide inhibits feeding behavior in A. rubens 402 
Based on the anatomical expression of the NGFFYamide precursor transcript in the digestive system 403 
using mRNA in situ hybridisation and the previously reported effect of NGFFYamide on the cardiac 404 
stomach both in vitro and in vivo (Semmens et al., 2013), we hypothesised that NGFFYamide may 405 
affect feeding behaviour in A. rubens.  406 
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 407 
Injection of starfish with NGFFYamide (10 µl of 10-4 M NGFFYamide) caused a significant increase 408 
in the time for starfish to make first contact with a mussel (“time to touch”; p < 0.0005; Figure 10A) 409 
and in the time to adopt a feeding posture (“time to enclose”; p < 0.005; Figure 10B). During the 410 
five-hour observation period, five NGFFYamide-treated starfish touched the mussel two times before 411 
enclosing. One starfish from the control group was discarded from the analysis, as it had atypically 412 
not fed on a mussel during the 24 hours after treatment.  413 
3.5 NGFFYamide causes a reduction in locomotor activity in A. rubens 414 
Based on the expression of the NGFFYamide precursor transcript in tube feet, the effect of 415 
NGFFYamide on in vitro tube foot preparations (see section 3.3) and the increased time to initiate 416 
feeding (see section 3.4), we hypothesised that NGFFYamide may affect locomotor activity in A. 417 
rubens.  418 
 419 
In vivo administration of NGFFYamide (10 µl of 10-4 M NGFFYamide) caused a significant decrease 420 
in the mean velocity of locomotor activity (Figure 11A) and the total distance travelled (Figure 11B) 421 
for the period of time from ten-and-half minutes to sixteen-and-a-half minutes after treatment (p < 422 
0.05). NGFFYamide treatment did not affect the maximum acceleration (10.1 ± 4.4 cm/s2 for control- 423 
and 5.7 ± 1.6 cm/s2 for NGFFYamide-treated group) or the cumulative time spent on the floor (169.6 424 
± 65.6 seconds for control and 211 ± 22.2 seconds for NGFFYamide-treated group) during the same 425 
time period. Furthermore, analysis of activity during each one-minute period of the six-minute 426 
experiment revealed significant differences between control and NGFFYamide-treated groups (p < 427 
0.05) at time points from two-to-three minutes and from three-to-four minutes (Figure 11C-D).  428 
 429 
4  Discussion 430 
Here, we report the characterisation of a NG peptide-type neuropeptide signalling system in the 431 
starfish A. rubens. Our demonstration that the amidated pentapeptide NGFFYamide acts as a ligand 432 
for an A. rubens NPS/CCAP-type receptor is consistent with our previously reported discovery that 433 
the structurally similar neuropeptide NGFFFamide acts as a ligand for an NPS/CCAP-type receptor 434 
in the sea urchin S. purpuratus (Semmens et al., 2015). Collectively, these findings provide definitive 435 
proof that NG peptides in echinoderms are orthologs of NPS in vertebrates and CCAP in 436 
protostomes. Furthermore, the discovery of the NGFFYamide signalling system in A. rubens has 437 
provided a basis for (i) investigation of the physiological roles of NGFFYamide in starfish, (ii) 438 
comparison of the actions of NGFFYamide with what is known about the actions of NG peptides in 439 
other echinoderms and (iii) comparison of the actions of NPS/NG peptide/CCAP-type neuropeptides 440 
in different phyla, as discussed below. 441 
 442 
4.1.  Functional characterisation of NGFFYamide signalling in the starfish A. rubens 443 
 444 
We reported previously that NGFFYamide causes dose-dependent contraction of cardiac stomach 445 
preparations from A. rubens in vitro and triggers retraction of the everted cardiac stomach when 446 
administered in vivo (Semmens et al., 2013). Here, our observation that the NGFFYamide precursor 447 
transcript is detected in cells located in the mucosa or basiepithelial nerve plexus layer of the cardiac 448 
stomach is consistent with these pharmacological effects of NGFFYamide. Furthermore, these 449 
findings indicate that NGFFYamide may be released by cells in the cardiac stomach to regulate its 450 
contractile state physiologically. The context in which NGFFYamide is released by cells in the 451 
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cardiac stomach remains to be determined. However, plausible scenarios are that NGFFYamide is 452 
released physiologically to trigger retraction of the cardiac stomach when extraoral feeding on prey is 453 
completed and/or to trigger premature retraction of the cardiac stomach if predators or other external 454 
stressors are sensed during a feeding bout. Informed by these observations and conclusions, here we 455 
investigated if in vivo injection NGFFYamide affects the normal feeding behaviour of starfish. 456 
Interestingly, we found that intracoelomic injection of NGFFYamide caused a significant increase in 457 
the time taken to make contact with prey (a mussel) and a significant increase in the time taken to 458 
enclose a mussel as a prelude to extraoral feeding. The physiological relevance of this effect of 459 
NGFFYamide remains to be elucidated and further insights may be obtained if the location of 460 
NGFFYamide receptors in A. rubens can be determined. Nevertheless, one possibility is that a direct 461 
effect of NGFFYamide on the contractile state of the cardiac stomach and/or a direct effect of 462 
NGFFYamide on the nervous system inhibits appetitive behaviour of starfish. Another possibility is 463 
that the effect of NGFFYamide on feeding behaviour is an indirect consequence of effects of 464 
NGFFYamide on locomotor systems and locomotor activity in starfish. Therefore, here we also 465 
investigated the in vitro effects of NGFFYamide on organs and muscle system associated with 466 
locomotor activity in starfish and the in vivo effects of NGFFYamide on locomotor activity in 467 
starfish, as discussed below. 468 
 469 
Our analysis of the anatomical distribution of the NGFFYamide precursor transcript in A. rubens 470 
revealed expression not only in the central nervous system (radial nerve cords, circumoral nerve ring) 471 
and digestive system, but also in other organs. Thus, NGFFYamide precursor-expressing cells are 472 
present in the coelomic lining of the apical muscle, a thickening of the longitudinally orientated body 473 
wall muscle layer located in an aboral and sagittal position in each arm. Investigation of the in vitro 474 
effect of NGFFYamide on apical muscle preparations revealed that it causes relaxation, partially 475 
reversing the contracting action of ACh. However, the effect of NGFFYamide on the apical muscle 476 
was quite modest. Thus, NGFFYamide caused only an 11-12 % reversal of the contraction induced 477 
by 10-6 M ACh, when tested at concentrations of 10-6 M or 10-5 M. Furthermore, at these 478 
concentrations NGFFYamide had no effect on preparations contracted with 10-5 M ACh. By way of 479 
comparison, other neuropeptides are more effective as relaxants of the apical muscle preparation. 480 
Thus, when tested at a concentration of 10-6 M, the SALMFamide-type neuropeptide S2, the pedal 481 
peptide-type neuropeptide ArPPLN1b and the calcitonin-type neuropeptide ArCT cause ~8 %, ~16 % 482 
and ~40 % reversal of contraction induced by application of 10-5 M ACh to apical muscle 483 
preparations (Lin et al., 2017; Cai et al., 2018). Nevertheless, the discovery that NGFFYamide acts as 484 
a relaxant of the apical muscle adds to a growing list of neuropeptides that regulate the contractile 485 
state of this preparation, which also include neuropeptides that cause contraction of the apical muscle 486 
in A. rubens – the gonadotropin-releasing hormone type neuropeptide ArGnRH and the corazonin-487 
type neuropeptide ArCRZ (Tian et al., 2017). 488 
 489 
Consistent with the expression of the NGFFYamide precursor transcript in cells associated with the 490 
locomotory tube feet of starfish, we found that NGFFYamide had an excitatory effect on in vitro 491 
preparations of tube feet. Thus, application of NGFFYamide triggered phasic contractions of tube 492 
feet that were superimposed upon an increase in basal tone. Furthermore, there was concentration-493 
dependency in the effect of NGFFYamide on both the amplitude and the frequency of the phasic 494 
contractions. This action of NGFFYamide on tube feet is interesting because it is the first 495 
neuropeptide that we have found to have this type of excitatory effect on tube feet. Thus, we have 496 
reported previously that the neuropeptides ArGnRH and ArCRZ cause dose-dependent tonic 497 
contraction of tube foot preparations (Tian et al., 2017), whereas NGFFYamide is so far unique 498 
amongst the neuropeptides that have been tested on starfish tube foot preparations in inducing 499 
initiation of phasic contractions. This effect of NGFFYamide suggests that it acts to induce activation 500 
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of an endogenous motor rhythm generator and therefore NGFFYamide may be important 501 
physiologically in regulating the co-ordinated stepping action of tube feet when starfish move. 502 
Informed by these observations, we investigated the effect of in vivo injection of NGFFYamide on 503 
locomotor activity of starfish and, interestingly, we found that NGFFYamide causes a significant 504 
reduction in velocity and the distance travelled. How can we reconcile what at first sight appear to be 505 
inconsistent effects of NGFFYamide at the level of individual tube feet in vitro and whole-animals in 506 
vivo? If, as suggested above, NGFFYamide participates in neural mechanisms that regulate initiation 507 
and/or maintenance of the rhythmic stepping action of tube feet, then a consequence of in vivo 508 
injection of NGFFYamide may be a pharmacological disruption of finely tuned endogenous 509 
neurochemical and electrophysiological tube foot control systems. Therefore, the inhibitory effect of 510 
NGFFYamide on whole-animal locomotor activity is not necessarily indicative of the physiological 511 
role of this neuropeptide. Nevertheless, in combination, the in vitro effects of NGFFYamide on tube 512 
feet and the in vivo effect of NGFFYamide on locomotor activity indicate that NGFFYamide has a 513 
physiological role in regulation of tube foot and locomotor activity in starfish. 514 
 515 
Discovery of the inhibitory effect of NGFFYamide on locomotor activity may also have relevance to 516 
the inhibitory effect of NGFFYamide on feeding behaviour. Our assessment of the effect of 517 
NGFFYamide on feeding behaviour in starfish involved measurement of the time taken to make 518 
contact with prey and the time taken to adopt a feeding posture and therefore the inhibitory effect of 519 
NGFFYamide on these activities could simply be manifestations of a general inhibitory effect on 520 
locomotor activity. Therefore, it remains to be established whether or not NGFFYamide actually has 521 
a direct effect on the initiation of feeding behaviour in starfish. Nevertheless, the previously reported 522 
powerful effect of NGFFYamide in triggering cardiac stomach contraction and retraction are strong 523 
indicators that this neuropeptide may be important physiologically in mediating termination of 524 
feeding activity in starfish. 525 
 526 
4.2.  Comparative analysis of the physiological roles of NG peptides in echinoderms 527 
 528 
Having analysed both the anatomical expression pattern and bioactivity of NGFFYamide in the 529 
starfish A. rubens, it is of interest to make comparisons with what is known about the physiological 530 
roles of NG peptides in other echinoderms. The first NG peptide to be identified in an echinoderm 531 
was NGIWYamide, which was isolated from the sea cucumber A. japonicus on account of its effect 532 
in causing contraction of longitudinal body wall muscles in this species (Iwakoshi et al., 1995). 533 
Subsequently, NGFFFamide was found to cause contraction of tube foot and oesophagus 534 
preparations from the sea urchin E. esculentus (Elphick and Rowe, 2009) and NGFFYamide was 535 
found to cause contraction of cardiac stomach preparations from the starfish A. rubens (Semmens et 536 
al., 2013). However, NG peptides do not only act to cause tonic contraction of muscle preparations in 537 
echinoderms. This has been illustrated in this study with the finding that NGFFYamide causes 538 
relaxation of ACh-contracted apical muscle preparations and triggers phasic contractions of tube foot 539 
preparations. Accordingly, analysis of the in vitro pharmacological effects of NGIWYamide in A. 540 
japonicus has similarly revealed differing actions on different preparations from this species. Thus, 541 
whilst NGIWYamide induces tonic contraction of both longitudinal body wall muscle and tentacle 542 
preparations, it also causes inhibition of spontaneous phasic contractions of intestine preparations 543 
(Inoue et al., 1999). Thus, in both starfish and sea cucumbers, NG peptides have myoexcitatory or 544 
myoinhibitory effects. However, the physiological significance and mechanisms of the differing 545 
actions of NG peptides on different muscle preparations from starfish and sea cucumbers remain to 546 
be determined. Furthermore, the actions of NGIWYamide are not restricted to effects on muscle 547 
activity as this peptide also causes stiffening of body wall mutable collagenous tissue (Birenheide et 548 
al., 1998) and induction of oocyte maturation and spawning (Kato et al., 2009) in A. japonicus. Thus, 549 
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we can conclude that NG peptides are pleiotropic neuropeptides in echinoderms and it is likely that 550 
other physiological roles of NG peptides in echinoderms will be discovered if their actions are further 551 
investigated using a variety of bioassays. 552 
 553 
4.3. Comparison of physiological roles NPS/NG peptide/CCAP-type neuropeptides: 554 
conservation or diversification of neuropeptide function? 555 
 556 
The functional characterisation of echinoderm NG peptides that are orthologs of NPS-type 557 
neuropeptides in vertebrates and CCAP-type neuropeptides in protostomes has provided a basis for 558 
comparison of the physiological roles of NPS/NG peptide/CCAP-type neuropeptides and 559 
investigation of the evolution of neuropeptide function in this neuropeptide family. To facilitate this, 560 
it is necessary to first provide a brief overview of what is known about the physiological roles of 561 
NPS-type neuropeptides in vertebrates and CCAP-type neuropeptides in protostomes. 562 
 563 
NPS was first discovered as a constituent of brain extracts that is the endogenous ligand for the 564 
“orphan” G-protein coupled receptor GPR154 (Sato et al., 2002).Thus, nothing was known about its 565 
physiological roles when NPS was first identified. Functional characterisation of NPS revealed that it 566 
increases locomotor activity in mice, increases wakefulness in rats and has anxiolytic-like effects in 567 
mice exposed to stressful conditions (Xu et al., 2004), actions that have been confirmed and 568 
examined in more detail in subsequent studies on rodents (Roth et al., 2006; Jungling et al., 2008; 569 
Meis et al., 2008; Okamura et al., 2008; Camarda et al., 2009; Duangdao et al., 2009; Paneda et al., 570 
2009; Peng et al., 2010; Li et al., 2015). Furthermore, evidence that the anxiolytic effect of NPS in 571 
rodents is also applicable to humans has emerged with the discovery that a coding polymorphism in 572 
the NPSR is associated with panic disorder (Okamura et al., 2007; Domschke et al., 2011). Roles of 573 
NPS in regulation of other physiological/behavioural processes in mammals have also been revealed, 574 
including immune cell activity and asthma susceptibility (Pulkkinen et al., 2006), irritable bowel 575 
syndrome/inflammatory bowel disease (D'Amato et al., 2007) and inhibition of food intake (Beck et 576 
al., 2005; Smith et al., 2006; Cline et al., 2007; Cline et al., 2008; Peng et al., 2010; Cifani et al., 577 
2011). However, interestingly, one study has revealed that NPS can increase food intake in rodents, 578 
which may occur through the activation of orexin-expressing neurons (Niimi, 2006). 579 
 580 
Turning to CCAP, this neuropeptide was first discovered as a cardioexcitatory peptide in crustaceans 581 
(Stangier et al., 1987) and subsequent studies have revealed cardioexcitatory effects of CCAP-type 582 
neuropeptides in insects (Cifani et al., 2011; Estevez-Lao et al., 2013). Furthermore, there is 583 
substantial evidence that CCAP is one of several neuropeptides that regulate shedding of the 584 
exoskeleton (ecdysis) in arthropods. Thus, a dramatic increase in circulating levels of CCAP has been 585 
observed in two crustacean species during ecdysis (Phlippen et al., 2000). Furthermore, CCAP 586 
activates an ecdysis motor program in the moth Manduca sexta (Gammie and Truman, 1997; Zitnan 587 
and Adams, 2000; Fuse and Truman, 2002), ablation of CCAP-expressing neurons results in failure 588 
of pupal ecdysis in Drosophila melanogaster (Park et al., 2003; Clark et al., 2004) and reducing 589 
expression of CCAP and its receptor by RNA interference causes failure of ecdysis in the beetle 590 
Tribolium castaneum (Arakane et al., 2008; Cifani et al., 2011). Other actions of CCAP in insects 591 
that have been reported include induction of oviduct contractions in the locust Locusta migratoria 592 
(Donini et al., 2001), inhibition of locomotor activity in the cockroach P. americana (Mikani et al., 593 
2015) and stimulation of gut contraction and secretion of digestive enzymes in cockroaches (Sakai et 594 
al., 2004; Sakai et al., 2006). Thus, CCAP is a pleiotropic neuropeptide in insects, with roles in 595 
regulation of a variety of physiological/behavioural processes. Currently, very little is known about 596 
the physiological roles of CCAP-type neuropeptides in non-arthropodan protostomes. However, 597 
evidence of roles in regulation of feeding behavior in the mollusc (pond snail) Lymnaea stagnalis 598 
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(Vehovszky et al., 2005) and regulation of egg-laying in the mollusc (cuttlefish) Sepia officinalis 599 
(Endress et al., 2018) has been reported. 600 
 601 
Do any common themes emerge from this overview of the actions of NPS/CCAP-type neuropeptides 602 
in vertebrates and protostomes by way of comparison with the actions of NG peptides in 603 
echinoderms? Clearly, there are huge differences in the anatomical organisation of the nervous 604 
systems, digestive systems and muscle systems of vertebrates, echinoderms and protostomes, which 605 
complicate comparisons of neuropeptide function. Nevertheless, it remains of interest to identify any 606 
similarities/differences at the level of physiological processes and behaviour. Effects on locomotor 607 
activity recur, with both stimulatory (rodents) and inhibitory (cockroaches, starfish) actions reported. 608 
Likewise, effects on the digestive system and on feeding behaviour have been reported in several 609 
taxa, including stimulation (cockroaches, starfish) or inhibition (sea cucumbers) of gut contractile 610 
activity and stimulation (pond snail, rodents) or inhibition (rodents, chicks, starfish) of feeding or 611 
feeding-related processes. Evidence of roles in regulation of reproductive processes also recur, with 612 
NGIWYamide triggering spawning in sea cucumbers and CCAP-type neuropeptides linked with egg-613 
laying in locusts and cuttlefish. Thus, there is evidence of both evolutionary conservation and 614 
diversification in the functions of NPS/NG peptide/CCAP-type neuropeptides. More investigations of 615 
the actions of this family of neuropeptides in a wider range of taxa, including other echinoderms and 616 
non-arthropodan protostomes, are now needed to gain deeper insights into the evolution of the 617 
physiological roles of NPS/NG peptide/CCAP-type neuropeptides in the Bilateria.    618 
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Figure legends 899 
 900 
Figure 1. Feeding behaviour of the starfish A. rubens in a laboratory setting. (A) Here a 901 
specimen of A. rubens can be seen making contact with a mussel (M. edulis) in an aquarium tank. In 902 
experiments reported in this paper, the time elapsed from when the starfish was placed at the opposite 903 
end of the tank to the mussel to when the starfish made contact with the mussel (“time to touch”) was 904 
measured and recorded. (B, C) Here a specimen of A. rubens can be seen enclosing a mussel at the 905 
onset of a feeding bout, with photographs taken from a side view (B) and from above (C). In 906 
experiments reported in this paper, the time elapsed from when the starfish was placed at the opposite 907 
end of the tank to the mussel to when the starfish enclosed the mussel (“time to enclose”) was 908 
measured and recorded. Scale bars: A: 2 cm; B: 2.5 cm; C: 1.5 cm. 909 
 910 
Figure 2. Recording locomotor activity of the starfish A. rubens in a laboratory setting. (A) 911 
Photograph of the experimental set-up, with a camera positioned above a Plexiglas aquarium (37 x 912 
19.8 x 25 cm) containing 7 l of seawater, with all the walls covered with white plastic and situated on 913 
top of a lightbox to enhance video contrast, which facilitated detection of the experimental animal by 914 
the video-tracking software Ethovision XT1. (B) Photograph showing the software arena settings, 915 
with the area defined as the floor in yellow (length of 33 cm) and a starfish positioned in the centre of 916 
the aquarium at the beginning of an experiment. (C) Photograph showing tracking of a starfish using 917 
Ethovision XT1, with the colour scale bar representing the time spent in one position (minimum in 918 
blue to maximum in red). Scale bars: A: 13.1 cm; B: 4.7 cm; C: 4.7 cm. 919 
 920 
Figure 3. Identification of an NPS/CCAP-type receptor in the starfish A. rubens that is 921 
activated by the neuropeptide NGFFYamide. (A) Phylogenetic tree showing that the A. rubens 922 
NPS/CCAP-type receptor (arrow) is positioned in a clade comprising NPS/CCAP-type receptors that 923 
is distinct from a clade comprising paralogous VP/OT-type receptors. Thyrotropin-releasing hormone 924 
(TRH)-type receptors were included here as an outgroup. Bootstrap support (1000 replicates) for 925 
each clade is represented with coloured stars as denoted in the key. Species in which the ligands 926 
for NPS/CCAP-type receptors and/or VP/OT-type receptors have been identified experimentally 927 
are shown with red lettering. Species: A. gam (Anopheles gambiae); A. jap (Apostichopus 928 
japonicus); A. med (Antedon mediterranea); A. rub (Asterias rubens); B. flo (Branchiostoma 929 
floridae); C. tel (Capitella teleta) D. mel (Drosophila melanogaster); E. fet (Eisenia fetida); H. 930 
sap (Homo sapiens); L. gig (Lottia gigantea); L. sta (Lymnaea stagnalis); S. kow (Saccoglossus 931 
kowalevskii); S. pur (Strongylocentrotus purpuratus); T. cas (Tribolium castaneum). The 932 
accession numbers of sequences included in the phylogenetic tree are listed in Supplementary 933 
Table 1. (B) Concentration-response curve showing that synthetic NGFFYamide (shown in red) 934 
activates the A. rubens NPS/CCAP-type receptor in CHO cells co-expressing the promiscuous G-935 
protein Gα16 and over-expressing the GFP-aequorin fusion protein G5A. Control experiments 936 
where CHO cells were transfected with an empty pcDNA 3.1(+) vector are shown in black. Each 937 
point (± s.e.m.) represents mean values from at least two independent experiments, with each 938 
experiment performed in triplicate. Concentration-response data are shown relative (%) to the 939 
maximal response (100% activation) observed in each experiment. The EC50 value for activation of 940 
the NPS/CCAP-type receptor with NGFFYamide is 2.1 x 10-13 M.  941 
 942 
Figure 4. Localisation of NGFFYamide precursor mRNA expression in the nervous system 943 
of A. rubens. (A) Transverse section of a radial nerve cord showing stained cells in the epithelium 944 
of the ectoneural region, largely concentrated laterally. Note the absence of stained cells in the 945 
hyponeural region. The boxed region is shown at a higher magnification in (B), where the 946 
elongate, bipolar shape of stained cells (arrowheads) can be seen. (C) Longitudinal section of a 947 
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radial nerve cord showing stained cells (arrowheads) along the length of the epithelium in the 948 
ectoneural region (arrowheads). (D) Stained cells (arrowheads) in the ectoneural epithelium of the 949 
circumoral nerve ring. (E) Transverse section of an arm showing stained cells (arrowhead) in the 950 
marginal nerve, which is located lateral to the outer row of tube feet on each side of the arm. 951 
Abbreviations: ec, ectoneural; hy, hyponeural; MN, marginal nerve; TF, tube foot. Scale bars: 952 
A: 33 µm; B: 16 µm; C: 16 µm; D: 33 µm; E: 16 µm. 953 
 954 
Figure 5. Localisation of NGFFYamide precursor mRNA expression in the digestive system 955 
of A. rubens. (A) Low magnification image showing stained cells (arrowheads) widely distributed 956 
in a section of a highly folded aboral region of the cardiac stomach. (B) Stained cells in the 957 
cardiac stomach, with the boxed region shown at a higher magnification in (C), where stained 958 
cells (arrowheads) can be seen to be located in the mucosal layer or just beneath the basiepithelial 959 
nerve plexus. (D) Transverse section of the central disk region showing the cardiac stomach, 960 
pyloric stomach, rectal caeca and apical muscle. Stained cells can be seen in the cardiac stomach, 961 
pyloric stomach and apical muscle (arrowheads) but not in the rectal caeca. A higher 962 
magnification image of expression in the apical muscle is shown in Figure 6E and the boxed 963 
region of the pyloric stomach is shown at higher magnification in (E). (F) Stained cells 964 
(arrowheads) in a transverse section of a pyloric duct. Abbreviations: AM, apical muscle; BNP, 965 
basiepithelial nerve plexus; CT, collagenous tissue layer; CS, cardiac stomach; ML, mucosal 966 
layer; PS, pyloric stomach; RC, rectal caeca; VML, visceral muscle layer. Scale bars: A: 33 µm; 967 
B: 16 µm; C: 6 µm; D: 33 µm; E: 16 µm; F: 16 µm. 968 
 969 
Figure 6. Localisation of NGFFYamide precursor mRNA expression in the tube feet, apical 970 
muscle and body wall of A. rubens. (A) Longitudinal sections of two tube feet, showing stained 971 
cells (arrowheads) in the sucker region. (B) Longitudinal sections of three tube feet, with the 972 
boxed region shown at higher magnification in (C); here stained cells (arrowhead) can be seen 973 
near to the basal nerve ring (*) and in the adhesive region of the tube foot sucker (arrow). (D) 974 
Transverse section of an arm showing stained cells (arrowheads) in the coelomic epithelium. (E) 975 
Transverse section at the junction between an arm and the central disk showing stained cells 976 
(arrowheads) in the coelomic epithelial lining the apical muscle. (F) Transverse section of an arm 977 
showing stained cells (arrowheads) in the external epithelium of the body wall. Abbreviations: 978 
AM = apical muscle; CE = coelomic epithelium; PS = pyloric stomach. Scale bars: A: 33 µm; B: 979 
33 µm; C: 6 µm; D: 16 µm; E: 16 µm; F: 16 µm. 980 
 981 
Figure 7. NGFFYamide causes relaxation of in vitro acetylcholine-contracted apical muscle 982 
preparations from A. rubens. A representative recording is shown, with 10-6 M NGFFYamide 983 
causing transient partial reversal of the contracting action 10-6 M acetylcholine (ACh). Application of 984 
ACh and NGFFYamide are labelled with upward pointing arrowheads and washing of the 985 
preparation is labelled with a downward pointing arrowhead. The graph shows the mean (± s.e.m.) 986 
relaxant effect of NGFFYamide when tested at a concentration of 10-6 M (n = 4).  987 
 988 
Figure 8. Application of NGFFYamide to in vitro tube foot preparations from A. rubens 989 
triggers phasic contractions that are superimposed upon an increase in basal tone. 990 
Representative recordings from a single tube foot preparation are shown, comparing the effect of (A) 991 
acetylcholine (ACh; 10-6 M) and the effect of (B) NGFFYamide (10-6 M). Application of ACh and 992 
NGFFYamide are labelled with upward pointing arrowheads and washing of the preparation is 993 
labelled with a downward pointing arrowhead. 994 
 995 
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Figure 9. The effects of NGFFYamide in causing both tonic and phasic contraction of tube foot 996 
preparations from A. rubens are concentration dependent. (A) Concentration-dependence of the 997 
effect of NGFFYamide in causing tonic contraction of tube feet. (B) Concentration-dependence of 998 
the effect of NGFFYamide on the peak amplitude of NGFFYamide-induced phasic contractions. (C) 999 
Concentration-dependence of the effect of NGFFYamide on the peak frequency of NGFFYamide-1000 
induced phasic contractions. The effects of NGFFYamide shown in (A) and (C) are normalized to the 1001 
contractile effect observed with 10-6 M Acetylcholine (ACh). Results are expressed as mean ± s.e.m. 1002 
(n = 6). Different letters indicate statistically significant differences (p < 0.05) by one-way ANOVA 1003 
(A) or Kruskal-Wallis test (B, C). 1004 
 1005 
Figure 10. Effects of in vivo injection of NGFFYamide on feeding behaviour in A. rubens. (A) 1006 
Injection of NGFFYamide (10 µl of 10-4 M NGFFYamide; shown in red) causes a significant 1007 
increase in the time elapsed (minutes) before starfish touch a mussel (see Figure 1A), by comparison 1008 
with control or vehicle-injected (10 µl of distilled water; shown in black) animals. (B) Injection of 1009 
NGFFYamide (10 µl of 10-4 M NGFFYamide; shown in red) causes a significant increase in the time 1010 
elapsed (minutes) before starfish enclose a mussel (see Figure 1B, C), by comparison with control or 1011 
vehicle-injected (10 µl of distilled water; shown in black) animals. Data are expressed as mean ± 1012 
s.e.m (n = 15 for control group; n = 17 for NGFFYamide-treated group). * indicates statistically 1013 
significant differences (p < 0.005) between vehicle-injected and the NGFFYamide-treated groups, as 1014 
determined by student t-test (A) or Welch’s t-test (B).  1015 
 1016 
Figure 11. Effects of in vivo injection of NGFFYamide on locomotor activity in A. rubens. 1017 
Graphs showing (A) mean velocity (cm/s) and (B) distance travelled (cm) over an entire six-minute 1018 
period, between ten-and-half minutes to sixteen-and-a-half minutes after injection with vehicle (10 µl 1019 
of distilled water; control group; shown in black) or NGFFYamide (10 µl of 10-4 M NGFFYamide; 1020 
shown in red). Graphs showing (C) mean velocity (cm/s) and (D) distance travelled (cm) during time 1021 
intervals of one-minute over a six-minute experiment, between ten-and-half minutes to sixteen-and-a-1022 
half minutes after injection with vehicle (10 µl of distilled water; control group; shown in black) or 1023 
NGFFYamide (10 µl of 10-4 M NGFFYamide; shown in red). Data are expressed as mean ± s.e.m (n 1024 
= 13 for control group; n = 14 for NGFFYamide-treated group). * indicates statistically significant 1025 
differences (p < 0.05) between control and NGFFYamide-treated groups, as determined by Student’s 1026 
t-test (A, B) or Mann-Whitney U-test (C, D), and # indicates statistically significant differences 1027 
determined by Kruskal-Wallis test within each group (black for control- and red for NGFFYamide-1028 
treated group; p < 0.005). 1029 











